Early Diagnosis Research Alliance
A new approach to early diagnosis – bringing the brightest research minds together to make earlier diagnosis in pancreatic cancer a reality.
Diagnosis of pancreatic cancer can take a long time, often with many visits to the doctors and possible misdiagnoses along the way. Around 80% of pancreatic cancer patients are not diagnosed until the cancer is at an advanced stage. At this late stage, surgery is usually not possible – and this is the only known treatment that has the potential to cure the disease.
Not only do we need to have the tools and knowledge to diagnose people at an earlier stage, but we also need to make the diagnosis process faster so that we don’t waste any precious time in moving people onto potentially life-saving surgery or other treatments.
Our committed and sustained investment in early diagnosis research means that we are nearer than ever before to significantly improving early diagnosis.
Through our Early Diagnosis Research Alliance and Early Diagnosis Workshop we have brought together the best minds in early diagnosis, bringing fresh new perspectives to address key challenges so that we can achieve earlier diagnosis in pancreatic cancer, faster.
There will always be improvements to be made in early diagnosis and so we also support early yet innovative approaches to early diagnosis through our Research Innovation Fund scheme that aims to transform early diagnosis in the long term.
Bringing together world leading experts in cancer research and other fields to find innovative new approaches to the early detection of pancreatic cancer.
Thanks to our supporters, through the projects above, we will make great strides in early diagnosis research. But we mustn’t stop there. More work will be needed to bring any breakthrough out of the lab and into the local hospital.